Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Cancer Research|August 5, 2016
Splenic Marginal Zone Granulocytes Acquire an Accentuated Neutrophil B-Cell Helper Phenotype in Chronic Lymphocytic LeukemiaMarcel Gätjen, Franziska Brand, Michael Grau, et al.
International Journal of Molecular Sciences|December 26, 2015
Poly-ε-caprolactone Coated and Functionalized Porous Titanium and Magnesium Implants for Enhancing Angiogenesis in Critically Sized Bone DefectsLaura Roland, Michael Grau, Julia Matena, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2023
Identification of Tensin-3 as a MALT1 substrate that controls B cell adhesion and lymphoma disseminationMélanie Juilland, Nagham Alouche, Ivana Ubezzi, et al.
Materials (Basel, Switzerland)|November 24, 2017
In Vitro Evaluation of PCL and P(3HB) as Coating Materials for Selective Laser Melted Porous Titanium ImplantsMichael Grau, Julia Matena, Michael Teske, et al.
Materials (Basel, Switzerland)|December 22, 2017
Osteointegration of Porous Poly-ε-Caprolactone-Coated and Previtalised Magnesium Implants in Critically Sized Calvarial Bone Defects in the Mouse ModelMichael Grau, Christian Seiler, Laura Roland, et al.
Oncotarget|February 10, 2018
Up-regulation of hexokinase II contributes to rituximab-chemotherapy resistance and is a clinically relevant target for therapeutic developmentJuan J Gu, Anil Singh, Kai Xue, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2011
Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell linesStephan Hailfinger, Hendrik Nogai, Christiane Pelzer, et al.
Cancer Research|January 15, 2020
Lymphoma Angiogenesis Is Orchestrated by Noncanonical Signaling PathwaysMarleen Gloger, Lutz Menzel, Michael Grau, et al.
Cell Reports|October 27, 2021
Lymphocyte access to lymphoma is impaired by high endothelial venule regressionLutz Menzel, Maria Zschummel, Tadhg Crowley, et al.
Cancer Cell|December 15, 2012
Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCLDaniel Nagel, Stefani Spranger, Michelle Vincendeau, et al.
Pageof 5